Three major reviews commissioned by the World Health Organization find that GLP-1 drugs including tirzepatide (sold as Mounjaro and Zepbound), semaglutide (Ozempic and Wegovy), and liraglutide ...

Natco Pharma shares climbed over 11% on February 16 after receiving approval to launch Semaglutide in India. Semaglutide is ...

By Tarun Sai Lomte Widely used weight-loss and diabetes drugs show clear benefits, but emerging evidence clarifies their side effects, rare risks, and what clinicians should monitor long term. Review: ...

Find out more about how tirzepatide performed better than semaglutide in weight reduction in a 2026 network meta-analysis.

Oral semaglutide lowers heart failure events in people with type 2 diabetes and existing heart failure without increasing ...

By Dr. Priyom Bose, Ph.D. An examination of user reviews finds that people continue off-label Ozempic when it delivers ...

This article was reviewed by Darragh O’Carroll, MD. Key Takeaways: You can get semaglutide injections (Ozempic® and Wegovy®) and oral semaglutide (Rybelsus®). Injections are usually more ...

An AI-designed obesity drug targeting the GIP receptor shows over 31% weight loss in preclinical tests, raising hopes for next-generation metabolic treatments beyond GLP-1 drugs.

Many semaglutide (e.g., Ozempic) users keep taking the drug because they see real weight loss or appetite reduction.  A Rutgers study analyzed anon ...

Researchers have discovered that drugs like Ozempic for diabetes and obesity also improve alcohol use disorders and other ...

Patients who use semaglutide for weight loss, like Ozempic, are more likely to continue the medication if they perceive it as ...

The FDA has outlined numerous concerns about the sale and use of unapproved GLP-1 drugs for weight loss.  “FDA is aware that ...